Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tigecycline vs Levofloxacin in Hospitalized Community-Acquired Pneumonia
NCT00079885Phase 3Completed
- Sponsor
- Pfizer
- Start
- Nov 2003
- Primary completion
- Jul 2005
- Modality
- Orthosteric Ligands
01
Overview
Phase 3, randomised, double-blind trial of tigecycline in community acquired pneumonia (CAP), sponsored by Pfizer. Primary endpoint: Clinical Response in the Clinically Evaluable Population. Started Nov 2003; status: completed.
02
Drugs
tigecycline
03
Conditions
community acquired pneumonia (CAP)
Beyond the preview
Go deeper on NCT00079885.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00079885.